homocystine has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carru, C; Deiana, L; Loriga, G; Pisanu, E; Satta, AE; Sotgia, S; Zinellu, A | 1 |
| Carrero, JJ; García-López, E; Lindholm, B; Stenvinkel, P; Suliman, ME | 1 |
1 review(s) available for homocystine and Dyslipidemia
| Article | Year |
|---|---|
Risk factors for cardiovascular disease in patients undergoing peritoneal dialysis.
Topics: Atherosclerosis; Cardiovascular Diseases; Dialysis Solutions; Disease Progression; Dyslipidemias; Homocystine; Humans; Hyperinsulinism; Inflammation; Insulin Resistance; Kidney Failure, Chronic; Peritoneal Dialysis; Risk Factors; Survival Analysis | 2007 |
1 trial(s) available for homocystine and Dyslipidemia
| Article | Year |
|---|---|
LDL S-homocysteinylation decrease in chronic kidney disease patients undergone lipid lowering therapy.
Topics: Allantoin; Apolipoproteins B; Azetidines; Cholesterol, LDL; Drug Combinations; Dyslipidemias; Ezetimibe, Simvastatin Drug Combination; Female; Homocystine; Humans; Hypolipidemic Agents; Lipid Metabolism; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Renal Insufficiency, Chronic; Simvastatin; Sulfhydryl Compounds; Uric Acid | 2012 |